Associate professor

Associate professor

Academic rank

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
June 11, 2020
BioSpace
Bold Therapeutics, a clinical-stage biopharmaceutical company, has expanded its COVID-19 collaborations to include four more academic researchers: Francois Jean , PhD and Ted Steiner , MD, both researchers from the University of British Columbia ; Stephen Barr , PhD, a researcher at Western University ; and Len Seymour , PhD, a r
BioSpace
May 22, 2020
BioSpace
Nektar Therapeutics (Nasdaq: NKTR) today announced the publication of Phase 1 clinical data for its lead immuno-oncology candidate, bempegaldesleukin (BEMPEG: NKTR-214) in combination with nivolumab, in Cancer Discovery, a journal of the American Association for Cancer Research. Previously published Phase 1 data in Cancer Discovery o
Bruce Y. Lee
May 17, 2020
Forbes
Should you be taking Vitamin D supplements during the pandemic?
October 1, 2019
WebWire
Fujitsu Limited today announced the establishment of the Fujitsu Group External Advisory Committee on AI Ethics, which is comprised of external experts. The committee will hold its first meeting today at Fujitsu's global headquarters in Tokyo. The committee aims to regularly discuss issues relating to ethics in the rapidly transforming field of AI, provide feedback to the Fujitsu Group AI Commitment( 1 ), and embark on an ongoing dialogue with stakeholders throughout society to support th...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.